Pangen Biotech Inc.

Samsung Electronics Co., Ltd.

Dobeel Co., Ltd.

Jaeseung Yoon

Taeho Byun

Jongmin Lee

Dong-jun Kim

Kyoungho Lee

Byung Cheol Ahn

Sangbong Lee

Chinkyu Kang

Jung Sun Yum

Kwanghee Baek

Ji Tai Kim

Joo Youn Lee

Jeong Soo Park

JeongSoo Park

Jeong Do Kim

Hankyu Oh

Jaepil Chung

Hye-Yeon Hwang

Yeup Yoon

Alex Inkeun Leesong

Hong Mo Moon

The present invention relates to an antibody specifically bound to a coagulation factor VIII or an antigen binding fragment thereof, and a use thereof. More specifically, the present invention relates to: an antibody which is specifically bound to a coagulation factor VIII including specific sequences of heavy chain CDR and light chain CDR, or an antigen binding fragment thereof; a column in which the antibody or the antigen binding fragment thereof is coupled to a column stationary phase as a ligand for isolating or purifying a recombinant coagulation factor VIII; and a method for purifying a recombinant coagulation factor VIII using the same.

Anti-coagulation factor VIII antibody and use thereof

There is provided an expression vector for animal cell having an increased gene expression efficiency, and particularly, an expression vector for animal cells including a MAR element and a SAR element, which are gene expression increasing factors, at a 5' end of a promoter, a 3&#x2032; end of a transcription termination site, or at both of the 5&#x2032; end of the promoter and the 3&#x2032; end of the transcription termination site. The expression vector for animal cells according to the present invention exhibits remarkably increased gene expression efficiency as compared to conventional expression vectors for animal cells, such that protein expression of foreign genes may be significantly increased using this expression vector for animal cells. Particularly, the expression vector for animal cells according to the present invention may be useful in that a high-expression cell line may be secured even without MTX amplification.

Expression vector for animal cells

A method for controlling a discontinuous reception (DRX) in a mobile communication device is provided. According to the method, when a specific application is selected, the device activates a DRX setting timer having a long DRX period for a direct long DRX mode, and enters into the DRX mode. When the setting timer expires in the DRX mode, the device activates the setting timer again and receives control information from a base station in an on-duration zone. The device enters into the DRX mode in response to no reception of valid control information in the on-duration zone, or enters into a continuous mode for executing the specific application in response to reception of valid control information.

Method for controlling discontinuous reception in mobile communication device

The present invention relates to mammalian expression vectors including nuclear matrix attachment region of human interferon &#x3b2;, and more particularly to pPGM-1, pPGM-2 and pPGM-3 including nuclear matrix attachment region of interferon &#x3b2; gene. Those expression vectors confer position independent expression of the introduced foreign gene, thus increasing the frequency of colonies which efficiently express the recombinant protein.

Expression vector for animal cell containing nuclear matrix attachment region of interferon beta

Growing community of inventors

Gyeonggi-do, South Korea

Jaeseung Yoon